biotech · Relapsed/Refractory Multiple Myeloma · Respiratory Distress Syndrome, Adult · INKT
MiNK Therapeutics
News and analysis for MiNK Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
NEW YORK, NY, SE HQ
2012 Founded
9 Employees
Public company Type
INKT · NYSE Ticker
Company details
- Status
- Public
- HQ
- NEW YORK, NY, SE
- Founded
- 2012
- Employees
- 9
- Programs
- 3
- Drugs
- 1
- Patents
- 6
News & analysis
NovaPharmaNews articles mentioning MiNK Therapeutics — regulatory, clinical, and market coverage.
News and analysis for MiNK Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.